{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T11:43:41Z","timestamp":1767008621799,"version":"build-2065373602"},"reference-count":20,"publisher":"Japan Atherosclerosis Society","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2025,11,1]]},"DOI":"10.5551\/jat.65696","type":"journal-article","created":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T22:07:29Z","timestamp":1754690849000},"page":"1464-1469","source":"Crossref","is-referenced-by-count":1,"title":["Combined Use of Statin and PCSK9 Inhibitor in a Pregnant Woman with Possible Familial Hypercholesterolemia and Coronary Artery Stenosis"],"prefix":"10.5551","volume":"32","author":[{"given":"Yusaku","family":"Shimizu","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, National Cerebral and Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tae","family":"Yokouchi-Konishi","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, National Cerebral and Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chizuko","family":"Aoki-Kamiya","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, National Cerebral and Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mai","family":"Temukai","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, National Cerebral and Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kotaro","family":"Hizuka","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, National Cerebral and Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masami","family":"Sawada","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, National Cerebral and Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aiko","family":"Kakigano","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, National Cerebral and Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoko","family":"Iwanaga","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, National Cerebral and Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Kanagawa","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, National Cerebral and Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kota","family":"Murai","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisashi","family":"Makino","sequence":"additional","affiliation":[{"name":"Department of Metabolic Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Yoshimatsu","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, National Cerebral and Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Abifadel M, Varret M, Rab\u00e8s JP, Allard D, Ouguerram K, Devillers M, Cruaud C, Benjannet S, Wickham L, Erlich D, Derr\u00e9 A, Vill\u00e9ger L, Farnier M, Beucler I, Bruckert E, Chambaz J, Chanu B, Lecerf JM, Luc G, Moulin P, Weissenbach J, Prat A, Krempf M, Junien C, Seidah NG, Boileau C: Mutations in PCSK9 cause autosomal dominant hypercholesterolemia. Nat Genet, 2003; 34: 154-156","DOI":"10.1038\/ng1161"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Iacocca MA, Chora JR, Carri\u00e9 A, Freiberger T, Leigh SE, Defesche JC, Kurtz CL, DiStefano MT, Santos RD, Humphries SE, Mata P, Jannes CE, Hooper AJ, Wilemon KA, Benlian P, O\u2019Connor R, Garcia J, Wand H, Tichy L, Sijbrands EJ, Hegele RA, Bourbon M, Knowles JW; ClinGen FH Variant Curation Expert Panel: ClinVar database of global familial hypercholesterolemia-associated DNA variants. Hum Mutat, 2018; 39: 1631-1640","DOI":"10.1002\/humu.23634"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Hori M, Ohta N, Takahashi A, Masuda H, Isoda R, Yamamoto S, Son C, Ogura M, Hosoda K, Miyamoto Y, Harada-Shiba M: Impact of LDLR and PCSK9 pathogenic variants in Japanese heterozygous familial hypercholesterolemia patients. Atherosclerosis, 2019; 289: 101-108","DOI":"10.1016\/j.atherosclerosis.2019.08.004"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Poornima IG, Pulipati VP, Brinton EA, and Wild RA: Update on statin use in pregnancy. Am J Med, 2023; 136","DOI":"10.1016\/j.amjmed.2022.08.029"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Raal FJ, Stein EA, Dufour R,Turner T, Civeira F, Burgess L, Langslet G, Scott R, Olsson AG, Sullivan D, Hovingh GK, Cariou B, Berthold I, Somaratne R, Bridges I, Scott R, Wasserman SM, and Gaudet D: PCSK9 inhibition with evolocumab (AMG 145) in heterozy- gous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial. Lancet, 2015; 385: 331-340","DOI":"10.1016\/S0140-6736(14)61399-4"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Suzuki T, Tsurane K, Umemoto T, Sasano T, Ushiki E, Fudono A, Hirose A, Sekiguchi M, and Miyasaka N: PCSK9 inhibitor use during pregnancy in a case of familial hypercholesterolemia complicated with coronary artery disease. J Obset Gynaecol Res, 2024; 50: 128-132","DOI":"10.1111\/jog.15813"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Tada H, Nohara A, Usui S, Sakata K, Kawashiri MA, Takamura M: Validation of the 2022 clinical diagnostic criteria of familial hypercholesterolemia in Japan. J Atheroscler Thromb, 2024; 31: 550-558","DOI":"10.5551\/jat.64549"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Makino H, Koezuka R, Tamanaha T, Ogura M, Matsuki K, Hosoda K, Harada-Shiba M: Familial Hypercholesterolemia and Lipoprotein Apheresis. J Atheroscler Thromb, 2019; 26: 679-687","DOI":"10.5551\/jat.RV17033"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Ogura M, Makino H, Kamiya C, Yoshimatsu J, Soran H, Eatough R, Perrone G, Harada-Shiba M, Stefanutti C: Lipoprotein apheresis is essential for managing pregnancies in patients with homozygous familial hypercholesterolemia: Seven case series and discussion. Atherosclerosis, 2016; 254: 179-183","DOI":"10.1016\/j.atherosclerosis.2016.10.018"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Alameh A, Jabri A, Aleyadeh W, Nasser F, Al Abdouh A, Kondapaneni M, Gulati M, Mattina D, Singh K, Hargrave J, Roselli EE, Khot UN, Cho L, Kalra A: Pregnancy-associated myocardial infarction: a review of current practices and guidelines. Curr Cardiol Rep, 2021; 23: 142","DOI":"10.1007\/s11886-021-01579-z"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Havakuk O, Goland S, Mehra A, Elkayam U: Pregnancy and the risk of spontaneous coronary artery dissection: an analysis of 120 contemporary cases. Circ Cardiovasc Interv, 2017; 10: 1-12","DOI":"10.1161\/CIRCINTERVENTIONS.117.004941"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Lewek J, Skowron B, Hachul C, Reiner \u017d, Banach M: Dyslipidaemia management in pregnant patients: a 2024 update. Eur Heart J Open, 2024; 4(3): oeae032","DOI":"10.1093\/ehjopen\/oeae032"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Ray KK, and Cannon CP: The potential relevance of the multiple lipid-independent (Pleiotropic) effects of statins in the management of acute coronary syndromes. J Am Coll Cardiol, 2005; 46: 1425-1433","DOI":"10.1016\/j.jacc.2005.05.086"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Vahedian-Azimi A, Makvandi S, Banach M, Reiner Z, and Sahebkar A: Fetal toxicity associated with statins: A systematic review and meta-analysis. Atherosclerosis, 2021; 327: 59-67","DOI":"10.1016\/j.atherosclerosis.2021.05.006"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Chang J, Chen Y, Chen I, Lin W, Chen Y, and Lin C: Perinatal outcomes after statin exposure during pregnancy. JAMA Netw Open, 2021; 4","DOI":"10.1001\/jamanetworkopen.2021.41321"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Hsieh CJ, Huang B: Rosuvastatin decreases testosterone levels but not sexual function in men with type 2 diabetes. Diabetes Research and Clinical Practice, 2016; 120: 81-88","DOI":"10.1016\/j.diabres.2016.07.026"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Rosenson RS, Hegele RA, Fazio S, and Cannon CP: The evolving future of PCSK9 inhibitors. J Am Coll Cardiol, 2018; 72: 314-329","DOI":"10.1016\/j.jacc.2018.04.054"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Clements T, Rice TF, Vamvakas G, Barnett S, Donaldson B, Jones CE, Kampmann B, and Holder B: Update on transplacental transfer of IgG subclasses: impact of maternal and fetal factors. Front Immunol, 2020; 11: 1920","DOI":"10.3389\/fimmu.2020.01920"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Agarwala A, Dixon DL, Gianos E, Kirkpatrick CF, Michos ED, Satish P, Birtcher KK, Braun LT, Pillai P, Watson K, Wild R, Mehta LS: Dyslipidemia management in women of reproductive potential: An expert clinical consensus from the National Lipid Association. J Clin Lipidol, 2024; 18: e664-e684","DOI":"10.1016\/j.jacl.2024.05.005"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Anderson PO: Monoclonal antibodies during breastfeeding. Breastfeed Med, 2021; 16: 591-593","DOI":"10.1089\/bfm.2021.0110"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/32\/11\/32_65696\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T04:17:31Z","timestamp":1761970651000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/32\/11\/32_65696\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,1]]},"references-count":20,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.65696","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"type":"print","value":"1340-3478"},{"type":"electronic","value":"1880-3873"}],"subject":[],"published":{"date-parts":[[2025,11,1]]},"article-number":"65696"}}